Clinical Supply Management Solutions
-
Global End-To-End Solutions
4/27/2023
Explore the benefits of a best-in-class Quality Management System, a global GMP Depot Network, Direct-to/From-Patient, Home Healthcare nursing services, and industry-leading expertise all under one single-source provider.
-
Clinical Trials Comparator And Co-Medication Sourcing Services
Learn how Thermo Fisher Scientific's Comparator Center of Excellence Team can assist you with developing the most cost effective strategy for securing the medications locally, regionally, globally or a combination.
-
How Can Phase 1 Trials Employ eClinical Solutions?
1/8/2024
Uncover how this unified platform is helping sponsors and CROs generate high-quality data, accelerate trials, and rapidly scale to Phase 2 and beyond.
-
Signant SmartSignals RTSM: Trial Supply Management, Optimized.
8/8/2023
Embark on a journey to uncover six compelling reasons behind adopting this RTSM solution, which boasts a modern front-end interface, for your upcoming study.
-
Tailored CDMO And Clinical Supply Solutions For Complex Needs
1/26/2026
Integrated analytical, manufacturing, packaging, and distribution capabilities streamline development and supply. Broad expertise and flexible services reduce handoffs and support efficient progress.
-
Simplify And Optimize Trial Supply Management
1/16/2024
Discover how Signant SmartSignals RTSM ensures the right patients get the right medications at the right time.
-
Adding eCOA To RTSM: Simplifying Workflow For Sites
12/9/2024
Simplify trials with Signant’s integrated SmartSignals eCOA and RTSM. Eliminate duplication, reduce reconciliation, and streamline operations for faster, error-free studies.
-
Advancing Your Product From Development To Commercialization
2/22/2023
Harnessing decades of global drug product development and commercialization, you can rely on PCI's integrated speed solutions to simplify the supply chain.
-
Dual Sourcing: Mitigating Risk In Your Supply Chain
8/22/2022
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.